Publication | Open Access

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

Sexual HealthParallel-group TrialTreatment And PreventionPro2000 Vaginal GelReproductive HealthGynecologyVaginitisHiv-1 InfectionHivMedicine